Antilipolytic drug boosts glucose metabolism in prostate cancer

INTRODUCTION: The antilipolytic drug Acipimox reduces free fatty acid (FFA) levels in the blood stream. We examined the effect of reduced FFAs on glucose metabolism in androgen-dependent (CWR22Rv1) and androgen-independent (PC3) prostate cancer (PCa) xenografts. METHODS: Subcutaneous tumors were pro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Andersen, Kim Francis, Divilov, Vadim, Koziorowski, Jacek, Pillarsetty, NagaVaraKishore, Lewis, Jason S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3662867/
https://ncbi.nlm.nih.gov/pubmed/23454248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2013.01.008
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky